Last update:

HIV & AIDS news

HIV & AIDS

Tuberculosis vulnerability of people with HIV: Viral protein implicated

According to the World Health Organization, tuberculosis accounts for one in three deaths among people living with HIV. In fact, even when receiving effective antiretroviral treatment, HIV-positive individuals are 15 to 30 ...

HIV & AIDS

An HIV outbreak in Maine shows the risk of Trump's crackdown on homelessness and drug use

Penobscot County, Maine, is grappling with the largest HIV outbreak in the state's history. Home to Bangor, a city of roughly 32,000, the county has identified 28 new cases over nearly two years. That's seven times the typical ...

HIV & AIDS

How HIV uses T cells to hide in the gut

Antiretroviral treatments for HIV (human immunodeficiency virus) have been extremely successful in extending life expectancy and reducing transmission. But one major challenge has so far prevented researchers from developing ...

Genetics

Comorbidities in HIV: Big data study reveals molecular links

Why do people infected with the human immunodeficiency virus (HIV) often suffer from cardiovascular, liver, and other comorbidities? Researchers at the Center for Individualized Infection Medicine (CiiM) investigated this ...

HIV & AIDS

Setback in the fight against pediatric HIV

For more than 20 years, Harvard infectious disease specialist Roger Shapiro has fought HIV on the ground in Botswana, where the rate of infection exceeded 30% in some areas of the country in the 1990s.

Medications

Poorer countries granted access to HIV prevention drug

Lower-income countries will gain access to a "game-changing" HIV prevention drug with a new deal signed between US pharmaceutical giant Gilead and the Global Fund, the health financing group said Wednesday.

HIV & AIDS

HIV prevention treatment shows gaps among key populations

A large, detailed look at patients taking HIV-prevention drug therapy finds strong adherence soon after patients get the prescription, but less consistent use thereafter, particularly among groups considered high priority ...

HIV & AIDS

Among persons with HIV, more finish short-course TB prophylaxis

(HealthDay)—Tuberculosis preventive treatment completion is higher with three months of rifapentine-isoniazid than six months of isoniazid among patients with HIV receiving antiretroviral therapy, according to a study published ...

Medications

Cabotegravir bests TDF-FTC for HIV prevention in those at risk

(HealthDay)—For men who have sex with men (MSM) and transgender women, long-acting injectable cabotegravir (CAB-LA, an integrase strand-transfer inhibitor [INSTI]) is superior to tenofovir disoproxil fumarate-emtricitabine ...

HIV & AIDS

Is it possible to deliver a knockout punch to HIV?

With a global focus on strategies to curb expansion of a fast-moving coronavirus pandemic, the question again has arisen: What more is being done about HIV, a scourge that has lasted more than 40 years—is a cure finally ...

Medical research

Faster test results mean better outcomes for HIV patients

Over the last 15 years, many African nations have made major strides towards enabling millions of HIV-positive people to access HIV antiretroviral therapy. This has helped to treat individual patients and maximize their health, ...

HIV & AIDS

Advancing the long-term well-being of people living with HIV

Since antiretroviral therapy (ART) for HIV was introduced in 1996, AIDS-related morbidity and mortality has declined significantly. People living with HIV are now expected to live nearly as long as people without HIV. Despite ...

HIV & AIDS

Screening program contributes to increase in HIV diagnoses

Newly published research shows that a screening program in the University of Cincinnati Medical Center Emergency Department helped detect an outbreak of HIV among persons who inject drugs in Hamilton County, Ohio, from 2014-18.